Search

1 to 10 of 205
Sort by

Event
34th Annual Meeting & Pre-Conference Programs (SITC 2019)

The 34 th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019) scheduled to take place Nov. 6-10, 2019, at the Gaylord National Hotel & Convention Center in National Harbor, Md. Click here to download a PDF flyer about SITC 2019. Dates to...

 11-06-2019 08:00 - 11-10-2019 12:00 ET
 National Harbor MD


Library Entry
2018 Advances in Cancer Immunotherapy™ - Boston, MA

2018 Advances in Cancer Immunotherapy TM - Boston, MA September 27, 2018 Wyndham Boston Beacon Hill Program Organizers Elizabeth Buchbinder, MD - Dana-Farber Cancer Institute David F. McDermott, MD - Beth Israel Deaconess Medical Center Virginia Seery, MSN, RN, ANP-BC - Beth Israel...

17 attachments



Library Entry
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article which details a retrospective study investigates the role of the NLR and dNLR as predictive markers of response to treatment with nivolumab in patients with advanced melanoma. Authors: Mariaelena Capone , ...



Web Page
SITC Meeting Code of Conduct

Anti-Harassment/Personal Safety and Security Approved by the SITC Executive Committee, June 2018 The Society for Immunotherapy of Cancer (SITC) is committed to provide a safe, secure, collegial and welcoming environment for all participants and attendees at its meetings and events, and to...


Event
Advances in Cancer Immunotherapy™ - Boston, MA

Organizers: David F. McDermott, MD – Beth Israel Deaconess Medical Center Elizabeth Buchbinder, MD – Dana-Farber Cancer Institute Virginia Seery, MSN, RN, ANP-BC – Beth Israel Deaconess Medical Center This program as already taken place. To find information on upcoming...

 09-27-2018 | 16:30 - 21:00 ET
 Boston MA


Library Entry
2018 Advances in Cancer Immunotherapy™ Post Program Webinar Series - Buffalo Webinar 2

From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) post-program webinar recording for the Buffalo event is provided here. The purpose of...


Library Entry
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report that describes a 73 year-old man in good health, who developed widely disseminated sebaceous carcinoma including metastases to brain, visceral organs, lymph nodes, and bone. Authors: Evidio Domingo-Musibay , Paari...


Library Entry
Thoracic and cutaneous sarcoid-like reaction associated with anti-PD-1 therapy: longitudinal monitoring of PD-1 and PD-L1 expression after stopping treatment

Published in the Journal for ImmunoTherapy of Cancer (JITC), is the first case report of a thoracic and cutaneous sarcoid-like reaction in a patient with a relapsing unresectable non-small cell lung cancer (NSCLC) treated with nivolumab, an anti-PD-1 mAb. Authors: Léa Paolini , Caroline...